Kazuo Kobayashi

2.0k total citations
86 papers, 1.3k citations indexed

About

Kazuo Kobayashi is a scholar working on Cardiology and Cardiovascular Medicine, Endocrinology, Diabetes and Metabolism and Physiology. According to data from OpenAlex, Kazuo Kobayashi has authored 86 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Cardiology and Cardiovascular Medicine, 19 papers in Endocrinology, Diabetes and Metabolism and 12 papers in Physiology. Recurrent topics in Kazuo Kobayashi's work include Blood Pressure and Hypertension Studies (17 papers), Heart Rate Variability and Autonomic Control (10 papers) and Diabetes Treatment and Management (9 papers). Kazuo Kobayashi is often cited by papers focused on Blood Pressure and Hypertension Studies (17 papers), Heart Rate Variability and Autonomic Control (10 papers) and Diabetes Treatment and Management (9 papers). Kazuo Kobayashi collaborates with scholars based in Japan, United States and Germany. Kazuo Kobayashi's co-authors include Masatoshi Fujishima, Susumu Ohmori, Koji Fujii, Yasuyuki Takata, M. Tominaga, Isao Abe, Tomohiro Koga, Yusuke Ohya, Yutaka Takata and Tatsuya Takagi and has published in prestigious journals such as Circulation Research, Biochemistry and Scientific Reports.

In The Last Decade

Kazuo Kobayashi

80 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Kazuo Kobayashi Japan 20 421 369 280 265 253 86 1.3k
Steven N. Levine United States 24 398 0.9× 161 0.4× 467 1.7× 404 1.5× 365 1.4× 57 1.8k
Riccardo Lacchini Brazil 24 447 1.1× 405 1.1× 343 1.2× 370 1.4× 124 0.5× 95 1.9k
Roman N. Rodionov Germany 20 444 1.1× 253 0.7× 150 0.5× 343 1.3× 120 0.5× 55 1.4k
Włodzimierz Buczko Poland 18 173 0.4× 367 1.0× 165 0.6× 335 1.3× 115 0.5× 75 1.2k
R. William Caldwell United States 16 462 1.1× 193 0.5× 113 0.4× 451 1.7× 103 0.4× 24 1.5k
Patrick Vallance United Kingdom 18 1.2k 2.8× 813 2.2× 150 0.5× 216 0.8× 231 0.9× 21 2.0k
Naoto Fukuyama Japan 25 583 1.4× 168 0.5× 105 0.4× 411 1.6× 260 1.0× 67 1.8k
W Buczko Poland 17 155 0.4× 260 0.7× 132 0.5× 277 1.0× 88 0.3× 48 1.1k
Yasutaka Maeda Japan 27 349 0.8× 303 0.8× 517 1.8× 661 2.5× 458 1.8× 76 2.0k
Marie–Françoise Doursout United States 20 261 0.6× 355 1.0× 56 0.2× 274 1.0× 385 1.5× 74 1.6k

Countries citing papers authored by Kazuo Kobayashi

Since Specialization
Citations

This map shows the geographic impact of Kazuo Kobayashi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kazuo Kobayashi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kazuo Kobayashi more than expected).

Fields of papers citing papers by Kazuo Kobayashi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kazuo Kobayashi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kazuo Kobayashi. The network helps show where Kazuo Kobayashi may publish in the future.

Co-authorship network of co-authors of Kazuo Kobayashi

This figure shows the co-authorship network connecting the top 25 collaborators of Kazuo Kobayashi. A scholar is included among the top collaborators of Kazuo Kobayashi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kazuo Kobayashi. Kazuo Kobayashi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kobayashi, Kazuo, Kei Takeshita, Takuya Hashimoto, et al.. (2025). Liver function effects of SGLT2 inhibitor and GLP‐1 receptor agonist combination treatment in patients with type 2 diabetes (post hoc analysis of RECAP study). Journal of Diabetes Investigation. 16(7). 1243–1253. 1 indexed citations
2.
Ito, Shun, Kazuo Kobayashi, Hareaki Yamamoto, et al.. (2022). Impact of the first announced state of emergency owing to coronavirus disease 2019 on stress and blood pressure levels among patients with type 2 diabetes mellitus in Japan. Journal of Diabetes Investigation. 13(9). 1607–1616. 2 indexed citations
3.
Matsumoto, Chisa, Shigeru Shibata, Takuya Kishi, et al.. (2022). Long COVID and hypertension-related disorders: a report from the Japanese Society of Hypertension Project Team on COVID-19. Hypertension Research. 46(3). 601–619. 24 indexed citations
4.
Tatematsu, Satoru, Kazuo Kobayashi, Yasunori Utsunomiya, et al.. (2021). Nationwide questionnaire survey on the management of chronic kidney disease for general practitioners in Japan. Clinical and Experimental Nephrology. 25(10). 1093–1102. 2 indexed citations
5.
Kawai, Yuki, Kazushi Uneda, Takayuki Yamada, et al.. (2021). Comparison of effects of SGLT-2 inhibitors and GLP-1 receptor agonists on cardiovascular and renal outcomes in type 2 diabetes mellitus patients with/without albuminuria: A systematic review and network meta-analysis. Diabetes Research and Clinical Practice. 183. 109146–109146. 28 indexed citations
6.
7.
Yamada, Masayuki, et al.. (2005). QT PRODACT: Inter- and Intra-facility Variability of the Action Potential Assay Using Isolated Guinea-Pig Papillary Muscles. Journal of Pharmacological Sciences. 99(5). 439–447. 4 indexed citations
8.
Matsuoka, Mayumi, Sayaka Maeda, M. Kai, et al.. (2000). Mycobacterium leprae typing by genomic diversity and global distribution of genotypes.. PubMed. 68(2). 121–8. 61 indexed citations
9.
Watanabe, Masashi, et al.. (2000). A Case of Hepatocellular Carcinoma with Resection of Pulmonary Metastases after Systemic Chemotherapy.. The Japanese Journal of Gastroenterological Surgery. 33(4). 492–496. 1 indexed citations
10.
Kamimura, Seiichiro, Junichi Takada, Kaoru Iwata, et al.. (1998). CASE REPORT: Insulin ‐ like growth factor II expression in hepatocellular carcinoma with alcoholic liver fibrosis accompanied by hypoglycaemia. Journal of Gastroenterology and Hepatology. 13(1). 47–51. 12 indexed citations
11.
Abe, Isao, et al.. (1997). Aortoiliac Occlusion Associated with the Lupus Anticoagulant. Angiology. 48(4). 359–364. 4 indexed citations
12.
Mimura, Kazuo, F. Umeda, Tetsuo Yamashita, et al.. (1995). Effects of Glucose and an Aldose Reductase Inhibitor on Albumin Permeation Through a Layer of Cultured Bovine Vascular Endothelial Cells. Hormone and Metabolic Research. 27(10). 442–446. 8 indexed citations
13.
Tominaga, Mitsuhiro, Koji Fujii, Isao Abe, et al.. (1994). Hypertension and ageing impair acetylcholine-induced vasodilation in rats. Journal of Hypertension. 12(3). 259???268–259???268. 50 indexed citations
14.
Takata, Yutaka, T Yoshizumi, Yasuo Ito, et al.. (1992). Comparison of withdrawing antihypertensive therapy between diuretics and angiotensin converting enzyme inhibitors in essential hypertensives. American Heart Journal. 124(6). 1574–1580. 19 indexed citations
15.
Funahashi, Kimihiko, et al.. (1991). Clinical Significance of Flow Cytometric Analysis of DNA Content in Colorectal Carcinoma.. The Japanese Journal of Gastroenterological Surgery. 24(8). 2176–2182. 3 indexed citations
16.
Kobayashi, Kazuo, et al.. (1989). Studies on the nonspecific immunological parameters in the pre-and the post-operative patients with gastric cancer.. The Japanese Journal of Gastroenterological Surgery. 22(1). 43–52. 1 indexed citations
17.
Honda, Ryoichi, et al.. (1989). Clinical evaluation of splenectomy for immunological influence in surgery of the gastric cancer.. The Japanese Journal of Gastroenterological Surgery. 22(11). 2606–2614. 2 indexed citations
18.
Eto, T., Ikuro Abe, Kenshi Kumamoto, et al.. (1989). Evaluation of Programs for the Diagnosis, Treatment and Follow-up of Hypertension in work Site Population. Clinical and Experimental Hypertension Part A Theory and Practice. 11(8). 1455–1470. 1 indexed citations
19.
Onoyama, Kaoru, Ikuro Abe, Shuichi Takishita, et al.. (1987). Pathophysiology in malignant hypertension: With special reference to the renin‐angiotensin system. Clinical Cardiology. 10(9). 513–518. 9 indexed citations
20.
Kobayashi, Kazuo, et al.. (1981). [Inhibition of serum choline esterase by fatty acids and the recovery by human serum albumin (author's transl)].. PubMed. 29(9). 925–8.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Steven N. Levine Breakdown of academic impact, for papers by Riccardo Lacchini Breakdown of academic impact, for papers by Roman N. Rodionov Breakdown of academic impact, for papers by Włodzimierz Buczko Breakdown of academic impact, for papers by R. William Caldwell Breakdown of academic impact, for papers by Patrick Vallance Breakdown of academic impact, for papers by Naoto Fukuyama Breakdown of academic impact, for papers by W Buczko Breakdown of academic impact, for papers by Yasutaka Maeda Breakdown of academic impact, for papers by Marie–Françoise Doursout
Rankless by CCL
2026